Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Di Maio

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Le Infezioni in Medicina|June 1, 2021
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019Barbara Rossetti, Lorenzo Paglicci, Velia C Di Maio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapiesVelia C Di Maio, Valeria Cento, Ilaria Lenci, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Le Infezioni in Medicina|June 1, 2021
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019Barbara Rossetti, Lorenzo Paglicci, Velia C Di Maio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapiesVelia C Di Maio, Valeria Cento, Ilaria Lenci, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 2